Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prolonged partial aortic occlusion worsens neurologic outcomes without affecting brain lesion size in a swine model of traumatic brain injury and hemorrhage.

The journal of trauma and acute care surgery·2026
Same author

Age-Based Screening for Lung Cancer Surveillance in the US.

JAMA network open·2025
Same author

Comparing Tabletop and High-Fidelity Simulation for Disaster Medicine Training in Emergency Medicine Residents.

Disaster medicine and public health preparedness·2025
Same author

Percutaneous Ablation of Parathyroid Adenomas: A Systematic Review and Meta-Analysis.

The Journal of clinical endocrinology and metabolism·2025
Same author

Exploring Radiofrequency Ablation for T1 Papillary Thyroid Cancer in the United States: Mayo Clinic Experience.

Mayo Clinic proceedings·2024
Same author

Effectiveness of a virtual reality trainer for retention of tourniquet application skills for hemorrhage control among emergency medicine residents.

AEM education and training·2024

Related Experiment Video

Updated: Jul 8, 2026

A Rat Model of Compound Acne
03:10

A Rat Model of Compound Acne

Published on: November 1, 2024

Hidradenitis suppurativa: an update.

Robert A Lee1, Andrew Yoon, Joseph Kist

  • 1Hospital of the University of Pennsylvania, Department of Dermatology, 3600 Spruce St., 2 Maloney, Philadelphia, PA 19104, USA. robert.lee@uphs.upenn.edu

Advances in Dermatology
|December 28, 2007
PubMed
Summary

New immunosuppressive medications offer hope for hidradenitis suppurativa (HS) treatment, potentially reducing the need for surgery. Long-term effects and risks require further study, emphasizing the need for standardized efficacy evaluation.

Related Experiment Videos

Last Updated: Jul 8, 2026

A Rat Model of Compound Acne
03:10

A Rat Model of Compound Acne

Published on: November 1, 2024

Area of Science:

  • Dermatology
  • Immunology
  • Medical Therapeutics

Background:

  • Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition often resistant to conventional treatments.
  • The advent of novel immunosuppressive agents has transformed dermatological treatment paradigms.
  • These medications target key inflammatory pathways implicated in HS pathogenesis.

Purpose of the Study:

  • To review the potential of new immunosuppressive medications in managing hidradenitis suppurativa.
  • To discuss the implications of these therapies as alternatives to surgical interventions.
  • To highlight the need for further research into long-term efficacy and safety.

Main Methods:

  • Review of current medical literature on immunosuppressive therapies for HS.
  • Analysis of treatment efficacy evaluation challenges and existing classification systems.
  • Presentation of a treatment algorithm based on disease severity.

Main Results:

  • Immunosuppressive medications show potential to significantly reduce inflammation and induce remission in HS.
  • These therapies may provide an alternative to excisional surgery for some patients.
  • Challenges remain in evaluating treatment response due to a lack of standardized metrics.

Conclusions:

  • New immunosuppressive drugs represent a promising advancement in HS management.
  • Careful consideration of potential risks, including malignancy and infection, is crucial.
  • A multidisciplinary approach and clear patient communication are vital for optimal HS care.